ArticleCureus2024
Malignant Transformation of a Choroidal Nevus.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Choroidal nevus is the most common intraocular tumor, and most cases are benign and have no symptoms. However, choroidal nevus carries a low risk for transformation into melanoma, which is a highly aggressive and deadly cancer. In this case report, we present a male patient with blurred vision in his left eye for six months. Multimodal fundus imaging reported a large pigmented gray-brown choroidal lesion adjacent to the optic disc in his left eye, along with intraretinal and subretinal fluid (SRF) accumulation involving the macula and fluorescein leakage. Choroidal nevus was then diagnosed, and bevacizumab was given by intravitreal injection. After one month of bevacizumab treatment, spectral-domain optical coherence tomography showed a decrease in SRF. After four months of bevacizumab treatment, the patient suffered from more SRF and an elevated lesion in his left eye. During subsequent follow-up, the lesion continued to increase in size. Given the possibility of a malignant transformation of choroidal nevus into melanoma, transpupillary thermotherapy (TTT) was performed. The choroidal melanoma appeared to be necrotic at 10 months post-TTT. The patient's left eye was enucleated due to neovascular glaucoma 17 months post-TTT. Histopathologic examination showed diffuse infiltration of melanoma cells in the retina, choroid and optic nerve, and cell growth on the surface of the optic nerve papilla. Multiple treatment modalities, including external beam radiotherapy and systemic chemotherapy, were applied, but the patient eventually died due to metastasis. Patients with choroidal nevus should be managed with multimodal fundus imaging and be closely followed up due to the risk of transformation into a malignant melanoma. For cases with clinical and imaging features of malignant transformation, early intervention and long-term follow-up are required to achieve local disease control and vision preservation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.